SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Suven Life Sciences gets nod to incorporate subsidiary in Singapore

09 Jul 2026 Evaluate

Suven Life Sciences has received approval to incorporate a wholly owned subsidiary (WOS) namely ‘Suven Neurosciences’ in Singapore. The new entity will be the Clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for treatment of neurological and other disorders.

The board of directors of the company, at its meeting held on July 08, 2026, has inter-alia considered and approved the same.

Suven Life Sciences provides wide range of Drug Discovery and Development Support Services (DDDSS) to global Pharma and Biotech companies. Suven has state-of-art facilities with highly qualified & experienced team of scientists.

Suven Life Sciences Share Price

326.60 -14.75 (-4.32%)
17-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1933.10
Dr. Reddys Labs. 1210.85
Cipla 1418.40
Lupin 2442.10
Zydus Lifesciences 1142.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: